IL-37: A new player in immune tolerance

Cytokine

Volumn 72, Issue 1, 2015, Pages 113-114

  Chen, Hui min ^a   Fujita, Mayumi ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Contact hypersensitivity; Immune tolerance; Interleukin 37; Tolerogenic dendritic cells

Indexed keywords

CYTOKINE; INTERLEUKIN 37; UNCLASSIFIED DRUG; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ADAPTIVE IMMUNITY; ALLERGY; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPH NODE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THYMUS; ANIMAL; IMMUNOLOGY; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1; MICE; MICE, TRANSGENIC;

EID: 84922319788     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.11.025     Document Type: Article

References (27)

1. Wood K.J., Bushell A., Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012, 12:417-430.
2. Dudek A.M., Martin S., Garg A.D., Agostinis P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol 2013, 4:438.
3. Luo Y., Cai X., Liu S., Wang S., Nold-Petry C.A., Nold M.F., et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci USA 2014, 111:15178-15183.
4. Dinarello C.A., Bufler P. Interleukin-37. Semin Immunol 2013, 25:466-468.
5. McNamee E.N., Masterson J.C., Jedlicka P., McManus M., Grenz A., Collins C.B., et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011, 108:16711-16716.
6. Nold M.F., Nold-Petry C.A., Zepp J.A., Palmer B.E., Bufler P., Dinarello C.A. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010, 11:1014-1022.
7. Ballak D.B., van Diepen J.A., Moschen A.R., Jansen H.J., Hijmans A., Groenhof G.J., et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 2014, 5:4711.
8. Hoebe K., Janssen E., Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004, 5:971-974.
9. Granucci F., Zanoni I., Feau S., Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 2003, 22:2546-2551.
10. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008, 8:193-204.
11. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
12. Ji Q., Zeng Q., Huang Y., Shi Y., Lin Y., Lu Z., et al. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediators Inflamm 2014, 2014:165742.
13. Fujita H., Inoue Y., Seto K., Komitsu N., Aihara M. Interleukin-37 is elevated in subjects with atopic dermatitis. J Dermatol Sci 2013, 69:173-175.
14. Aslan C., Ak H., Askar N., Ozkaya A.B., Ergenoglu A.M., Yeniel A.O., et al. Overexpression of complement C5 in endometriosis. Clin Biochem 2014, 47:496-498.
15. Li Y., Wang Z., Yu T., Chen B., Zhang J., Huang K., et al. Increased Expression of IL-37 in Patients with Graves' Disease and Its Contribution to Suppression of Proinflammatory Cytokines Production in Peripheral Blood Mononuclear Cells. PLoS ONE 2014, 9:e107183.
16. Li C., Zhao P., Sun X., Che Y., Jiang Y. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome. Mediators Inflamm 2013, 2013:639712.
17. Li C., Ji H., Cai Y., Ayana D.A., Lv P., Liu M., et al. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. J Interferon Cytokine Res 2013, 33:612-618.
18. Imaeda H., Takahashi K., Fujimoto T., Kasumi E., Ban H., Bamba S., et al. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol 2013, 172:410-416.
19. Moschen A.R., Molnar C., Enrich B., Geiger S., Ebenbichler C.F., Tilg H. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med 2011, 17:840-845.
20. Zhao P.W., Jiang W.G., Wang L., Jiang Z.Y., Shan Y.X., Jiang Y.F. Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS ONE 2014, 9:e95346.
21. Song L., Qiu F., Fan Y., Ding F., Liu H., Shu Q., et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 2013, 33:111-117.
22. Ye L., Ji L., Wen Z., Zhou Y., Hu D., Li Y., et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 2014, 12:69.
23. Ye Z., Wang C., Kijlstra A., Zhou X., Yang P. A possible role for interleukin 37 in the pathogenesis of Behcet's disease. Curr Mol Med 2014, 14:535-542.
24. Gulati N., Suarez-Farinas M., Fuentes-Duculan J., Gilleaudeau P., Sullivan-Whalen M., Correa da Rosa J., et al. Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights. J Invest Dermatol 2014, 134:2531-2540.
25. Zhao J.J., Pan Q.Z., Pan K., Weng D.S., Wang Q.J., Li J.J., et al. Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells. Sci Rep 2014, 4:5177.
26. Wan Z.Y., Sun Z., Song F., Chen Y.F., Zhang W.L., Wang H.Q., et al. Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration. Int J Clin Exp Pathol 2014, 7:656-662.
27. Ye Z., Wang C., Tang J., Zhou Y., Bai L., Liu Y., et al. Decreased interleukin-37 expression in vogt-koyanagi-harada disease and upregulation following immunosuppressive treatment. J Interferon Cytokine Res 2014.